AstraZeneca's Tagriso trial shows 'meaningful improvement', Lynparza recommended for EU marketing
21st Sep 2020 08:36
(Sharecast News) - Pharmaceutical giant AstraZeneca issued updates on the status of several drug candidates early on Monday.
Read moreIllness in phase three trial not linked to Covid-19 vaccine, Oxford says
17th Sep 2020 12:50
(Sharecast News) - The Covid19 vaccine being trialled by AstraZeneca and the University of Oxford was likely not behind the symptoms of one participant which led to the pause in the phase three trials last week, documents provided to the volunteers show.
Read moreNIH 'very concerned' about serious side effect in AstraZeneca vaccine trial - CNN
16th Sep 2020 15:24
(Sharecast News) - The US part of the phase three trial of the Covid-19 vaccine candidate being developed by AstraZeneca and the University of Oxford remains on hold, pending authorisation for a restart from independent safety monitors and America's health regulator, the Food and Drug Administration.
Read moreNo safety issues with Covid-19 vaccine trial so far - Pfizer
15th Sep 2020 23:25
(Sharecast News) - Pfizer's phase three clinical trial for its Covid-19 vaccine candidate has encountered no safety problems even after over 12,000 volunteers had been administered a second dose.
Read moreEurope close: Stocks end mixed despite gains for travel and leisure names
14th Sep 2020 18:57
(Sharecast News) - European stocks finished the session on a mixed note, despite news at the weekend that AstraZeneca has resumed the key clinical trial for the Covid-19 vaccine candidate that it's developing with the University of Oxford.
Read moreUniversity of Oxford and AstraZeneca restart Covid-19 vaccine trial
12th Sep 2020 15:55
(Sharecast News) - The University of Oxford and AstraZeneca will resume trials of their Covid-19 vaccine candidate after receiving clearance from the UK's Medicines Health Regulatory Authority.
Read moreAstraZeneca boss says Covid-19 vaccine may still be ready by end 2020
10th Sep 2020 14:37
(Sharecast News) - AstraZeneca's boss said that the Covid-19 vaccine that it was developing together with the University of Oxford could still be ready by the end of 2020.
Read moreAstraZeneca asthma drug Fasenra meets endpoints in Phase 3 trial
10th Sep 2020 09:00
(Sharecast News) - AstraZeneca said on Thursday that its Fasenra asthma drug met both co-primary endpoints in a phase III trial for patients with chronic rhinosinusitis with nasal polyps.
Read moreEurope midday: Stocks move higher as tech stocks bounce on Wall Street
9th Sep 2020 14:27
(Sharecast News) - Stocks in Europe are moving higher tracking a bounce on Wall Street with investors for the moment shrugging off news that AstraZeneca had paused the phase three clinical trials of its leading Covid-19 vaccine candidate.
Read moreJefferies says short-term correction in AstraZeneca may prove misplaced
9th Sep 2020 13:25
(Sharecast News) - Analysts at Jefferies reiterated their 'hold' recommendation for shares of AstraZeneca following the pharma giant's decision to press the pause button on its phase three clinical trial for the Covid-19 vaccine under development alongside the University of Oxford.
Read moreBioNTech and Pfizer announce positive result in pre-clinical trial for Covid-19 vaccine
9th Sep 2020 12:52
(Sharecast News) - One of the Covid-19 vaccine candidates being developed by German outfit BioNTech and Pfizer succeeded in pre-clinical challenge trials.
Read moreOxford Biomedica slumps as AstraZeneca vaccine trial halted
9th Sep 2020 08:31
(Sharecast News) - Oxford Biomedica shares slid on Wednesday on news that AstraZeneca and Oxford University's Covid-19 vaccine trial has been put on hold, as investors fretted over how this might affect the gene and cell therapy company's supply deal with the UK pharmaceuticals giant.
Read moreOxford/AstraZeneca Covid-19 drug trial paused as participant falls ill
9th Sep 2020 07:53
(Sharecast News) - Final trials for a potential coronavirus vaccine being developed by AstraZeneca and Oxford University, have been paused after a participant had an adverse reaction in the UK.
Read moreAstraZeneca pauses Covid-19 vaccine trial to review safety data
9th Sep 2020 01:13
(Sharecast News) - AstraZeneca paused the phase three clinical trial of the Covid-19 vaccine candidate that it was developing in conjunction with the University of Oxford, in response to a possible unexplained illness in one of the participants.
Read moreGlobal pharma bosses vow to put science first in race for Covid-19 vaccine
8th Sep 2020 11:52
(Sharecast News) - The bosses of nine of the world's largest pharmaceutical companies pledged to put science and safety first in the race to find a vaccine for Covid-19.
Read more